Cia27 on rat chromosome 10 is a collagen-induced arthritis (CIA) severity quantitative trait locus originally identified in a study of (DA Â ACI) F2. As an initial step towards the positional cloning of the Cia27 gene, a 17 cM (21 Mb) interval from the DA strain (arthritis-susceptible) containing the two-logarithm of odds support interval comprising Cia27 was introgressed into the ACI (arthritis-resistant) background through genotype-guided congenic breeding. ACI.DA(Cia27) congenics developed a significantly more severe form of arthritis (CIA), with a 5.9-fold increase in median arthritis severity index, a parameter known to correlate with synovial inflammation, and cartilage and bone erosions, compared with ACI (Pp0.001). The arthritis severity enhancing effect could be detected from day 21 onwards. Rats heterozygous at the congenic interval developed a disease similar to ACI rats, suggesting that DA alleles operate in a recessive manner. Levels of autoantibodies anti-rat type II collagen did not correlate with arthritis severity. Synovial tissue mRNA levels of interleukin-1b (IL-1b) were significantly increased in ACI.DA(Cia27) congenics compared with ACI. These results demonstrate that Cia27 harbors a novel arthritis severity regulatory gene. The identification of this gene should facilitate the identification of the rheumatoid arthritis gene mapped to the human syntenic region on chromosome 17q22-q25.
Introduction
Rheumatoid arthritis (RA) is a complex trait with a strong genetic component that affects 0.5-1% of the population. 1, 2 Several major histocompatability complex (MHC) and non-MHC susceptibility loci [3] [4] [5] [6] [7] have been recently mapped and a few of their respective genes [8] [9] [10] have been identified. However, the identity of most susceptibility genes remains largely unknown. Among the difficulties involved in gene identification are the inherent characteristics of complex traits, which include variable penetrance, variable relative risk associated with the disease allele and epistasis, and the genetic heterogeneity of human populations. 11 Additionally, yet unidentified sex factors appear to regulate the penetrance of certain arthritis-regulatory alleles, making some disease alleles sex-specific. [12] [13] [14] [15] [16] [17] Little is known about the genetic regulation of disease severity and none of the RA multi-institutional familybased genome-wide screens was designed to address disease severity. These severity genes could have a more significant role in the perpetuation (chronicity) of the inflammatory process and joint damage, and thus could generate better targets for drug development.
Studies of rodent models of arthritis in intercrosses generated with inbred strains that differ in their susceptibility to and severity of disease can overcome several difficulties involved in complex trait analyses, thus having the potential to facilitate gene identification. 11, 18 Once identified, these rodent arthritis genes will provide novel targets for focused candidate gene, or candidate pathway analysis in RA case-control studies.
In order to identify non-MHC loci regulating disease severity in collagen-induced arthritis (CIA), an F2 intercross was generated between MHC RT1 av1 identical DA (arthritis-susceptible) and ACI (arthritis-resistant) strains. Five non-MHC arthritis regulatory quantitative trait loci (QTL), and a major gender effect were identified. 16, 19 One of these loci, named Cia27 in the present study, reached a maximum logarithm of odds (LOD) score of 2.6 closest to D10Wox7, 19 and raised great interest because of its location in a region of rat chromosome 10 implicated in the regulation of several autoimmunity phenotypes and diseases, 20, 21 including arthritis in rodents [22] [23] [24] and humans. 4, 25 Therefore, as a second step towards identification of the gene accounting for Cia27, we report here that ACI.DA(Cia27) congenic rats were generated and studied for their susceptibility to and severity of autoimmune arthritis induced with CIA. The transfer of the Cia27 interval from DA rats into ACI rats was enough to significantly increase CIA severity in congenic rats, compared with ACI rats. Additionally, the Cia27 gene regulates synovial tissue levels of IL-1b, a cytokine known to be central to the pathogenesis of arthritis.
Material and methods

Rats
Specific pathogen-free ACI (ACI/Hsd) (CIA-resistant) and DA (DA/Hsd) (CIA-susceptible) inbred rat strains were purchased from Harlan-Sprague Dawley (Indianapolis, IN, USA) and used in the breeding of the congenic strain.
Construction of the genotype-guided Cia27 QTL-congenic A 17 cM (21 Mb) interval containing the 10 cM two-LOD support intervals comprising Cia27 was transferred from the arthritis-susceptible DA strain to the arthritisresistant ACI strain ( Figure 1 ). There was no evidence of genomic imprinting in DA Â ACI F2 intercross genome-wide scan, and therefore, two DA Â ACI and two ACI Â DA mating pairs were used (using the convention of female Â male). DA Â ACI and ACI Â DA breeders produced F1 rats. Two male F1 offspring were backcrossed to ACI females, producing N2 generation offspring. Tail-tips were excised at age 3-4 weeks, and DNA extracted with the DNeasy kit (Qiagen, Valencia, CA, USA). These progeny (and the following generations) were genotyped with simple sequence length polymorphic (SSLP) markers on chromosomes 2 (Cia7: D2Arb1, D2Mgh19, Cpb1, D2Rat38; Cia10: D2Mit12, D2Wox20, D2Rat55, D2Mgh29), 10 (Cia27: D10Rat19, D10Mit12, D10Wox7, D10Rat2) and 12 (Cia25: D12Wox12, D12Arb15, D12Mgh3, D12Arb3, D12Rat53) that we have found to contain QTLs that regulate arthritis severity in the DA Â ACI F2 intercross. 16, 19 Polymerase chain reaction (PCR) conditions have been previously reported, and were set up in 10 ml reactions. 16 All PCRs used a fluorescent-labeled forward primer and PCR products were run in ABI310 capillary genotypers/ sequencers (Applied Biosystems, ABI, Foster City, CA, USA). GENESCAN 3.1 software (ABI) was used for fluorescent-labeled PCR products' data extraction and allele assignment. All genotypes were manually checked by at least two readers, and questionable readings were rechecked or repeated. For marker details, see the Rat Genetic Database (http://www.niams.nih.gov/rtbc/ ratgbase/index.htm), 26 and the Rat Genome Database (http://www.rgd.mcw.edu). 27 We identified offspring that maintained the 17 cM Cia27 interval in the heterozygous state and had fixed the background strain alleles (ACI) to homozygosity for the other three arthritis QTL regions. These offspring were backcrossed again to the ACI strain, and progeny that maintained heterozygosity at Cia27 were selected for the breeding of the following generation. After five backcross generations (N6), pairs of rats heterozygous for a QTL region were intercrossed. Their progeny were genotyped to identify offspring homozygous for the DA alleles at the Cia27 interval (markers D10Rat19, D10Mit12, D10Wox7, D10Rat2). These founder rats were brother-sister mated to establish the congenic line and to produce offspring for use in arthritis experiments. Offspring from fifth and sixth intercross generations were used in the arthritis experiments. All the experiments involving animals were reviewed and approved by the Feinstein Institute for Medical Research Institutional Animal Care and Use Committee.
Induction of collagen-induced arthritis
Homologous rat type II (RII) collagen was prepared as previously described. 19, 28 Briefly, purified RII collagen (Chondrex, Redmond, WA, USA) was dissolved in 0.1 N acetic acid (41C, 2 mg/ml) and emulsified with an equal volume of cold incomplete Freund's adjuvant (IFA) (Difco, BD, Bio, Bedford, MA, USA). Eight to 12-weekold rats received intradermal injections on the back at a dose of 2 mg/kg. A booster injection of the RII-IFA emulsion (100 mg collagen in 0.1 ml) was injected at the base of the tail on day 7.
Based on previous observations that certain loci operate in a gender-specific manner, 12, 14, 15 males and females were first studied separately and then in combined analyses.
Arthritis scoring
We used a previously described arthritis scoring system 16, 19, 22, 29 that evaluates individual joints and weights the arthritis severity by joint size as follows: (a) interphalangeal, metacarpophalangeal and metatarsophalangeal joints: each one of the four lateral digits were scored 0 ¼ no arthritis; l ¼ arthritis present; (b) wrist, mid-forepaw, ankle and midfoot joints were scored 0 ¼ normal; l ¼ minimal swelling; 2 ¼ moderate swelling; To dissociate the severity and susceptibility components for independent analysis, susceptibility was defined as a score of one or higher in at least two consecutive scoring time points. Only rats meeting these susceptibility criteria were used in the analysis of ASI.
Measurement of anticollagen antibodies
Serum samples collected on day 18 after CIA induction were assayed in duplicates for IgG antibodies against rat type II collagen using commercially available enzymelinked immunosorbent assay (ELISA) Kits (Chondrex), according to the manufacturer's instructions.
Quantitative real-time polymerase chain reaction Tissue processing, RNA extraction, cDNA synthesis, primer sequences and real-time PCR methods have been previously reported. 23, 31 Briefly, synovial tissue was homogenized and total RNA isolated with the RNeasy Kit (Qiagen) and digested with DNase (Qiagen), according to the manufacturer's protocol, quantified with NanoDrop spectrophotometry (Nanodrop, Wilmington, DE, USA) and verified for integrity with a Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA). Five hundred nanograms of total RNA from each sample were used for cDNA synthesis (SUPERCRIPT III kit, Invitrogen, Carlbad, CA, USA). cDNA was optimized for relative gene expression by real-time PCR. The TaqMan 5 0 exonuclease assay was used for the quantification of the rat tumor necrosis factor-a (TNF-a) and IL-1b genes. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as endogenous control. The probes were labeled with FAM at the 5 0 end and TAMRA at the 3 0 end. Eurogentec qPCR mastermix (Eurogentec, San Diego, CA, USA) reagents were used in an ABI 7700 Sequence Detection System (ABI). The PCR reaction mixture contained 1X mastermix, 500 nM of either TNF-a, IL-1b or GAPDH forward and reverse primers, 200 nM of TNFa or IL-1b, or 100 nM of GAPDH gene-specific TaqMan probes and 5 ml of 1:10 diluted cDNA to a final volume of 25 ml. All samples were run in duplicates and the average used for the analyses. Thermocycler conditions were 501C for 2 min, 951C for 10 min and 45 cycles of 951C for 0.15 min and 601C for 1 min. Data were analyzed using Sequence Detection System (SDS) software version 1.9.1 (ABI). Results were obtained as C t (threshold cycle) values. The C t value is inversely proportional to the starting template copy number. Relative expression of TNFa and IL-1b in synovial tissues was adjusted for GAPDH in each sample (DC t ). ACI and ACI.DA(Cia27) congenic rats gene expression was also compared using the 2
ÀDDCt method. Figure 4 ). The susceptibility to CIA was not significantly affected by the Cia27 (combined male and female ACI susceptibility of 84.2%, n ¼ 19 and combined ACI.DA(Cia27) susceptibility of 88.8%, n ¼ 27; P ¼ 0.68, Fisher's exact test; data not shown). Figure 2 Clinical picture depicting ACI.DA(Cia27) congenic rats (a) and ACI rats (b) with collagen-induced arthritis. Congenic rats developed a significantly more severe arthritis than ACI rats. Arrowheads point to red and swollen interphalangeal joints.
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Serum levels of antibodies anti-RII collagen Serum obtained on day 18 following the induction of CIA were used to measure anti-RII collagen antibodies. All strains produced high levels of autoantibodies anti-RII, confirming proper immunization ( Figure 5 ). Despite developing a significantly milder disease, ACI females produced higher levels of anti-RII collagen antibodies, compared with ACI.DA(Cia27) females, confirming that the levels of antibodies were not a critical factor in the regulation of disease severity in Cia27 congenics, as previously suggested by the DA Â ACI F2 genome-wide scan. 16, 19 No significant differences in antibodies against RII collagen were detected in males.
Synovial tissue tumor necrosis factor-a and interleukin-1b mRNA levels are increased in ACI.DA(Cia27), compared with ACI rats Quantitative polymerase chain reaction (QPCR) analysis of RNA obtained from synovial tissues at day 32, revealed increased expression of IL-1b and TNF-a in ACI.DA(Cia27) (Figure 6a ). This increased expression translated into a median 1.69-fold increase in the amount of IL-1b (P ¼ 0.01; Figure 6b) , and 1.52-fold increase in TNF-a (P ¼ 0.1; Figure 6b ) in ACI.DA(Cia27), compared with ACI. The QPCR data not only support the clinical arthritis scoring, but also suggest that Cia27 regulates a cellular process involved in the regulation of IL-1b expression.
Discussion
Rat models of autoimmune arthritis studied in intercrosses generated between inbred strains that differ in their susceptibility to and severity of disease provide a powerful tool to facilitate the identification of loci regulating different stages in the disease course, 34, 35 as well as specific disease characteristics such as disease severity 19, 22, 29, 36 and the production of rheumatoid factors. 37 Additionally, the phenotypic effect of loci identified in linkage studies can be definitively confirmed in congenic strains, [12] [13] [14] 23, 24, 31, 38 such as described herein, thus providing the basis to the gene identification effort. 39 Findings from studies in rats can then be brought into RA studies for more focused analyses.
We have previously generated an intercross between the DA and ACI rat, two strains that share the same arthritis-prone MHC RT1 av1 haplotype. 19 A genome-wide scan in the (DA Â ACI) F2 intercross identified four novel non-MHC autosomal QTLs 16, 19 that reach the suggestive or definitive level of significance for linkage (LOD scores X2.8 and 4.3, respectively). 40 A fifth locus, Cia27, located in the telomeric segment of chromosome 10, was also Figure 4 Arthritis severity scores of ACI.DA(Cia27) (white circles) and ACI rats (black circles). Arthritis scores are significantly different as early as day 21, and remain significantly different through the end of the observation period (*P ¼ 0.029; **P ¼ 0.002; # Pp0.001). ACI.DA(Cia27) rats heterozygous at the congenic interval (gray squares) develop arthritis similar to ACI, demonstrating that DA alleles at Cia27 operate in a recessive manner (means7s.e.m.). Figure 5 Autoantibodies against rat type II collagen were measured on day 18 following the induction of CIA. All rats produced high levels of antibodies to RII collagen. ACI female rats produced higher levels than female ACI.DA(Cia27).
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Although the Cia27 peak LOD score was 2.6 closest to D10Wox7, and thus not definitive for linkage, 19 this locus was of great interest as it was in a region known to harbor several autoimmune disease regulatory loci in the rat, mouse and human genomes, including experimental arthritis loci Oia3 24 and Cia5a, 13, 23 and a RA chromosome 17q22-q25 susceptibility locus. 4, 25 The presence of DA-derived alleles only at the Cia27 interval was enough to induce a 5.9-fold increase in median ASI in both male and female ACI.DA(Cia27) congenics, compared with ACI rats. The ASI (cumulative arthritis severity scores over time) used here was previously shown to correlate with the degree of synovial inflammation, and cartilage and bone erosive changes 23, 30, 31 and therefore, it is also considered a predictor of chronic joint damage changes in arthritis.
(ACI.DA(Cia27) Â DA) backcross six (BC6) rats heterozygous at the congenic interval developed a disease identical to ACI, thus demonstrating that DA alleles operate in a recessive manner. This knowledge will be critical during the process of reducing the critical interval and positionally cloning the Cia27 gene, as the arthritic phenotype will have to be screened in homozygous recombinant and not in heterozygous offspring.
Both ACI.DA(Cia27) congenics and ACI rats immunized with RII collagen and IFA produced high levels of autoantibodies against RII collagen, but antibody levels did not correlate with disease severity, as previously suggested by the DA Â ACI F2 genome-wide scan. 16, 19 This is unlike the observation made in studies of the colocalizing locus Cia5a. DA alleles at the Cia5a locus significantly increased the levels of autoantibodies against RII collagen, and antibody levels correlated with disease severity. 23 These differences suggest that Cia27 and Cia5a are accounted for by different genes segregating in the DA Â ACI and DA Â F344 intercrosses, respectively. Yet, either Cia27 or Cia5a could account for the RA susceptibility locus on chromosome 17. 4, 25 Cia27 is a severity locus, and once the gene is identified the human syntenic gene will be studied in association tests using well-characterized cohorts with disease severity parameters. 41 Interleukin-1b is a key proinflammatory cytokine involved in the pathogenesis of rodent arthritis 42 and RA, and its pathway is the target for a Food and Drug Administration (FDA)-approved therapy (IL-1ra). 43 Rat IL-1b synovial protein levels have been reported to correlate with the amount of synovial mRNA. 44 Therefore, using QPCR we determined that IL-1b ( Figure 6 ) mRNA levels were 1.69-fold higher in congenic rats compared to ACI rats (day 32 postimmunization with RII collagen and IFA), suggesting that the Cia27 gene influences inflammatory processes upstream from this cytokine.
The ACI.DA(Cia27) congenics were generated after five backcrosses (N6) and 7-8 intercrosses. Theoretically, after the initial intercross and the following five backcrosses, there could still be a 1.5% contamination with DA donor genome outside the QTL region. The genotype-guided congenic breeding strategy used in this study excluded donor genome contamination at the other chromosomal regions known to regulate arthritis in the DA Â ACI F2 intercross. 16, 19 Therefore, any DA genome contamination outside the Cia27 interval would have occurred at a region that does not contain arthritis QTLs, and thus is unlikely to have influenced the arthritic phenotype.
The Cia27-containing 21 Mb interval on rat chromosome 10 includes a number of potentially interesting candidate genes, such as Slc9a3r1, Crhr1, Grb2, Stat3, Ace and others. However, sequencing candidate genes before the critical interval has been reduced to 1 cM or less is typically fruitless, as many polymorphisms are likely to be identified between two different stains, and difficult to prove as disease-causing.
Both the Cia27 interval on rat chromosome 10 region and its syntenic interval on mouse chromosome 11 contain loci regulating different models of autoimmune diseases 23, 24, [45] [46] [47] [48] and immunologic traits. 49, 50 Furthermore, Cia27 is syntenic to human chromosome 17q22- Collagen-induced arthritis in Cia27 congenic rats M Brenner et al q25, a region implicated in the susceptibility to RA, 4, 25 and other autoimmune diseases such as psoriasis 51, 52 and multiple sclerosis. 53 Taken together, these data raise the possibility that the same gene may regulate arthritis and other autoimmune diseases in rats, mice and humans. Although this clustering of non-MHC autoimmunity regulatory loci does not prove that these loci are accounted for by the same gene, it has certainly raised that possibility. 20 Recent human studies have in fact identified the first two genes involved in the regulation of more than one autoimmune disease, CTLA4 54 and PTPN22. 10, 55, 56 In conclusion, we have constructed ACI.DA(Cia27) congenic rats. Although this locus did not reach the suggestive levels for linkage in the original genome-wide screen in DA Â ACI F2 intercross, the introduction of DA alleles at this region into ACI background significantly increased arthritis severity scores in congenic rats. The localization of Cia27 to a region syntenic to a human RA susceptibility locus is very encouraging. We anticipate that the identification of the Cia27 gene will generate an important novel candidate gene, or candidate pathway, for focused case-control analyses in RA cohorts designed to study disease severity.
